Innowacyjność sektora farmaceutycznego

Katarzyna Nowicka

Gospodarka Narodowa-The Polish Journal of Economics, 2006, vol. 2006, issue 11-12

Abstract: The article discusses the involvement of pharmaceutical companies in the development of new drugs and therapies. The analysis shows that eight of the world’s 10 best-selling pharmaceuticals have originated in the United States, and two have been developed in Western Europe. Innovative brand-name drugs accounted for only 15 percent of the new pharmaceuticals registered in the United States in 1989-2000. All the other pharmaceuticals were generic drugs and modifications of pharmaceuticals already available on the market. Taxpayers and research institutes cover 85 percent of the costs of research into the development of new treatments. The role of generic drugs is growing—chiefly because f their more affordable prices compared with those of patented drugs. Not only private consumers, but also public sector institutions obligated to provide health services to citizens, have appreciated the attractiveness of generic drugs. After Poland’s accession to the European Union on May 1, 2004, Polish pharmaceutical producers have gained new opportunities to increase their competitive position. However, Poland is still far behind highly industrialized countries in the level of expenditure on research into the development of new pharmaceuticals and therapies. This means that decision makers in Poland must work to upgrade the legal system and encourage businesses to focus on pharmaceutical research, the author concludes.

Keywords: Health Economics and Policy; Research and Development/Tech Change/Emerging Technologies; Research Research Methods/Statistical Methods (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ageconsearch.umn.edu/record/356450/files/Nowicka.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:polgne:356450

DOI: 10.22004/ag.econ.356450

Access Statistics for this article

More articles in Gospodarka Narodowa-The Polish Journal of Economics from Szkoła Główna Handlowa w Warszawie / SGH Warsaw School of Economics Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().